Language:

Results 1 - 20 of 226 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2 3 4 5

Show only

Peer-reviewed Journals (216)

Result Number	Material Type	Record Details and Options
1	Material Type: Article	Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort Journal of clinical oncology, 2015-03, Vol.33 (9), p.992-999 [Peer Reviewed Journal] 2015 by American Society of Clinical Oncology. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2014.58.3302 ;PMID: 25667280 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
2	Material Type: Article	Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome Clinical cancer research, 2018-01, Vol.24 (1), p.33-42 [Peer Reviewed Journal] 2017 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Jan 1, 2018 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-17-1921 ;PMID: 29066508 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
3	Material Type: Article	The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC Journal of thoracic oncology, 2017-02, Vol.12 (2), p.194-207 [Peer Reviewed Journal] 2016 International Association for the Study of Lung Cancer ;Copyright © 2017 by the International Association for the Study of Lung Cancer ;Copyright © 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2016.10.003 ;PMID: 27729297 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
4	Material Type: Article	Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter? The European respiratory journal, 2017-06, Vol.49 (6), p.1601838-1601838 [Peer Reviewed Journal] Copyright ©ERS 2017. ;Copyright European Respiratory Society Journals Ltd. Jun 2017 ;Copyright ©ERS 2017 2017 ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.01838-2016 ;PMID: 28572122 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
5	Material Type: Article	Clinical features of large cell neuroendocrine carcinoma: a population-based overview The European respiratory journal, 2016-02, Vol.47 (2), p.615-624 [Peer Reviewed Journal] Copyright ©ERS 2016. ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.00618-2015 ;PMID: 26541538 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
6	Material Type: Article	Heat shock protein antagonists in early stage clinical trials for NSCLC Expert opinion on investigational drugs, 2017-05, Vol.26 (5), p.541-550 [Peer Reviewed Journal] 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2017 ;ISSN: 1354-3784 ;EISSN: 1744-7658 ;DOI: 10.1080/13543784.2017.1302428 Digital Resources/Online E-Resources View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
7	Material Type: Article	The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib British journal of clinical pharmacology, 2018-06, Vol.84 (6), p.1156-1169 [Peer Reviewed Journal] 2018 The British Pharmacological Society ;2018 The British Pharmacological Society. ;ISSN: 0306-5251 ;EISSN: 1365-2125 ;DOI: 10.1111/bcp.13534 ;PMID: 29381826 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
8	Material Type: Article	Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer Journal of thoracic oncology, 2017-10, Vol.12 (10), p.1552-1560 [Peer Reviewed Journal] 2017 International Association for the Study of Lung Cancer ;Copyright © 2017 by the International Association for the Study of Lung Cancer ;Copyright © 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;ISSN: 1556-0864 ;ISSN: 1556-1380 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2017.06.070 ;PMID: 28689043 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
9	Material Type: Article	Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy Journal of cachexia, sarcopenia and muscle, 2020-04, Vol.11 (2), p.424-431 [Peer Reviewed Journal] 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders ;2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2190-5991 ;EISSN: 2190-6009 ;DOI: 10.1002/jcsm.12526 ;PMID: 32045108 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
10	Material Type: Article	Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer Journal of clinical oncology, 2010-03, Vol.28 (8), p.1380-1386 [Peer Reviewed Journal] 2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2009.24.7221 ;PMID: 20142596 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
11	Material Type: Article	Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion European journal of nuclear medicine and molecular imaging, 2016-02, Vol.43 (2), p.240-248 [Peer Reviewed Journal] The Author(s) 2015 ;Springer-Verlag Berlin Heidelberg 2016 ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-015-3169-4 ;PMID: 26338178 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
12	Material Type: Article	Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer Molecular oncology, 2024-01 [Peer Reviewed Journal] 2023 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. ;ISSN: 1574-7891 ;EISSN: 1878-0261 ;DOI: 10.1002/1878-0261.13555 ;PMID: 38010703 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
13	Material Type: Article	The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab Journal of cachexia, sarcopenia and muscle, 2021-06, Vol.12 (3), p.657-664 [Peer Reviewed Journal] 2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders ;2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. ;2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2190-5991 ;EISSN: 2190-6009 ;DOI: 10.1002/jcsm.12698 ;PMID: 33951326 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
14	Material Type: Article	Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology Respiratory research, 2023-11, Vol.24 (1), p.1-271, Article 271 [Peer Reviewed Journal] COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1465-993X ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-023-02575-3 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
15	Material Type: Article	Identification of microRNAs in skeletal muscle associated with lung cancer cachexia Journal of cachexia, sarcopenia and muscle, 2020-04, Vol.11 (2), p.452-463 [Peer Reviewed Journal] 2019 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders ;2019 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2190-5991 ;EISSN: 2190-6009 ;DOI: 10.1002/jcsm.12512 ;PMID: 31828982 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
16	Material Type: Article	Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib CPT: pharmacometrics and systems pharmacology, 2024-04, Vol.13 (4), p.612-623 [Peer Reviewed Journal] 2024 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. ;2024 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. ;ISSN: 2163-8306 ;EISSN: 2163-8306 ;DOI: 10.1002/psp4.13105 ;PMID: 38375997 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
17	Material Type: Article	Characteristics of patients with advanced cancer preferring not to know prognosis: a multicenter survey study BMC cancer, 2022-09, Vol.22 (1), p.1-941, Article 941 [Peer Reviewed Journal] COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09911-8 ;PMID: 36050628 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
18	Material Type: Article	Reporting of Incidence and Outcome of Bone Metastases in Clinical Trials Enrolling Patients with Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma—A Systematic Review Cancers, 2021-06, Vol.13 (13), p.3144 [Peer Reviewed Journal] 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers13133144 ;PMID: 34201833 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
19	Material Type: Article	Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer Journal of clinical oncology, 2009-04, Vol.27 (12), p.2038-2045 [Peer Reviewed Journal] 2009 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2008.19.1650 ;PMID: 19307503 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
20	Material Type: Article	CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids Clinical cancer research, 2013-04, Vol.19 (8), p.2197-2207 [Peer Reviewed Journal] 2014 INIST-CNRS ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-12-3078 ;PMID: 23444222 ;CODEN: CCREF4 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by

Results 1 - 20 of 226 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2 3 4 5

Personalize your results

Edit

Add page to My Research

Refine Search Results

Expand My Results

Expand My Results

Show only

Peer-reviewed Journals (216)

on this subject:


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Results 1 - 20 of 226 for All Library Resources

2015 by American Society of Clinical Oncology. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2014.58.3302 ;PMID: 25667280

2017 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Jan 1, 2018 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-17-1921 ;PMID: 29066508

Copyright ©ERS 2017. ;Copyright European Respiratory Society Journals Ltd. Jun 2017 ;Copyright ©ERS 2017 2017 ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.01838-2016 ;PMID: 28572122

Copyright ©ERS 2016. ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.00618-2015 ;PMID: 26541538

2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2017 ;ISSN: 1354-3784 ;EISSN: 1744-7658 ;DOI: 10.1080/13543784.2017.1302428

2018 The British Pharmacological Society ;2018 The British Pharmacological Society. ;ISSN: 0306-5251 ;EISSN: 1365-2125 ;DOI: 10.1111/bcp.13534 ;PMID: 29381826

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2009.24.7221 ;PMID: 20142596

The Author(s) 2015 ;Springer-Verlag Berlin Heidelberg 2016 ;ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-015-3169-4 ;PMID: 26338178

2023 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. ;ISSN: 1574-7891 ;EISSN: 1878-0261 ;DOI: 10.1002/1878-0261.13555 ;PMID: 38010703

2009 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2008.19.1650 ;PMID: 19307503

2014 INIST-CNRS ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-12-3078 ;PMID: 23444222 ;CODEN: CCREF4

Results 1 - 20 of 226 for All Library Resources

Personalize your results

Refine Search Results

Expand My Results

Show only

Refine My Results

Creation Date

New Records

Resource Type

Subject

Databases

Journal Title

on this subject:

Searching Remote Databases, Please Wait